NCT05212168 - Norovirus Challenge Study | Biotech Hunter

Enrollment

165

Participants

Timeline

Start Date

December 27, 2021

Primary Completion Date

April 13, 2023

Study Completion Date

October 27, 2023

Conditions

Norovirus Infections

Interventions

BIOLOGICAL

VXA-G1.1-NN

Norovirus GI.1 Norwalk VP1 Vaccine, Oral E1-/E3-Deleted Replication Defective Recombinant Adenovirus 5 with dsRNA Adjuvant

OTHER

Placebo Tablets

Oral tablets similar in appearance and number to active vaccine tablets

BIOLOGICAL

Norovirus GI.1 Norwalk Virus Inoculum

Norwalk Virus Inoculum Lot 01-09NV

Trial Locations (1)

AltaSciences LA, Cypress